COGNEZENSE Labs OÜ is a OÜ based in Tallinn, registry code 16547433, status: active. Main activity: Other human health activities n.e.c.. According to EMTA, turnover for Q3 2026 was €4 503 with employees.
Turnover
4 503 €
↓ 45.0%vs Q2 2026
State taxes
1 581 €
↓ 38.0%vs Q2 2026
Labour taxes
686 €
↑ 0.0%vs Q2 2026
Employees
—
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry Human health activities · EMTAK 86
Turnover · Q3 20264 503 €
above 36% of companies
industry median 9 428 € · companies in the industry: 351
Revenue · 202515 216 €
above 45% of companies
industry median 20 811 € · companies in the industry: 3 373
Net profit margin · 2025-28.4 %
above 8% of companies
industry median 8.3 % · companies in the industry: 2 759
Taxes and turnover
Q4 2023 – Q3 2026
Turnover, € Q3 2026: 4 503 € · −45.0% vs Q2 2026 · industry median 9 428 € · above 36% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Labour taxes per employee, € Q2 2024: 0 € · industry median 2 205 € · above 2% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
EmployeesQ2 2024: 1 · +0.0% vs Q1 2024State taxes, € Q3 2026: 1 581 € · −38.0% vs Q2 2026
Figures by quarter
Quarter
Turnover, €
State taxes, €
Labour taxes, €
Employees
Q3 2026
4 503
1 581
686
—
Q2 2026
8 192
2 552
686
—
Q1 2026
4 425
1 470
624
—
Q4 2025
6 938
2 104
624
—
Q3 2025
3 517
1 180
624
—
Q2 2025
2 772
918
459
—
Q1 2025
3 099
2 347
—
—
Q4 2024
4 329
1 923
1 333
—
Q3 2024
5 403
71
—
—
Q2 2024
6 424
16
—
1
Q1 2024
4 663
42
—
1
Q4 2023
4 087
173
—
1
Q3 2023
3 440
—
—
1
Q2 2023
2 163
58
—
1
Q1 2023
3 836
—
—
1
Q4 2022
7 758
—
—
1
Q3 2022
—
—
—
1
Financials by year
2023 – 2025
Revenue, € 2025: 15 216 € · −23.1% vs 2024 · industry median 20 811 € · above 45% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit, € 2025: -4 326 € · −234.6% vs 2024 · industry median 1 071 € · above 9% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit margin, % 2025: -28.4 % · −44.7 pp vs the year before · industry median 8.3 % · above 8% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Assets, € 2025: 7 291 € · −41.4% vs 2024Equity, € 2025: 6 212 € · −41.1% vs 2024Employees2025: 1 · +0.0% vs 2024 · industry median 2 · above 5% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Financials by year
Year
Revenue, €
Net profit, €
Labour costs, €
Assets, €
Equity, €
Employees
2025
15 216
-4 326
6 136
7 291
6 212
1
2024
19 784
3 214
3 256
12 449
10 538
1
2023
24 372
11 193
0
14 718
14 523
0
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
-28.4 %
Net profit / revenue
Return on equity (ROE)
-69.6 %
Net profit / equity
Return on assets (ROA)
-59.3 %
Net profit / assets
Equity ratio
85.2 %
Equity / assets
Debt ratio
14.8 %
Liabilities / assets
Current ratio
6.76
Current assets / current liabilities
Revenue per employee
15 216 €
Revenue / average full-time employees
Labour cost per employee per month
511 €
Labour costs / employees / 12 months (incl. employer taxes)
